Role of Zinc Oxide on Rheology of Thermosensitive Gel Developed for Periodontitis Treatment

Abstract:

Periodontal disease is a major cause of tooth loss, therefore a more recent approach such as thermosensitive gel is loaded with antimicrobial drugs to be delivered locally to the periodontal pocket. The effect of ZnO on thermosensitive gel properties including gelation-gel melting temperature, rheology, syringeability, and the release behavior of antimicrobial drug such as doxycycline hyclate were investigated. The increased amount of ZnO apparently decreased the gelation temperature of the Lutrol® F127 system. Syringeability of the doxycycline hyclate-Lutrol® F127 systems were increased with the increased amount of ZnO. System comprising zinc oxide could prolong the release of doxycycline hyclate from Lutrol F127 systems and could be delivered from a syringe through a needle for utilizing in periodontitis therapy at the periodontal pocket.

• Periodical: Advanced Materials Research (Volumes 93-94)
• Pages: 479-484
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.93-94.479
• Online since: January 2010
• Authors: J. Mahadlek, J. Charoenteeraboon, Supab Choopun, Thawatchai Phaechamud
• Keywords: Periodontitis Treatment, Thermosensitive Gel, Zinc Oxide (ZnO)

References

[1] A.K. Schwach, C.N. Vivien and R. Gurny: Eur. J. Pharm. Biopharm Vol. 50 (2000), pp.83-99.

[2] H.M. Kelly, P.B. Deasy, E. Ziaka and N. Claffey: Int. J. Pharm Vol. 274 (2004), pp.167-18.

[3] N. Jain, G.K. Jain, S. Javed, Z. Iqbal, S. Talegaonkar, F.J. Ahmad and R.K. Khar: Drug Discov. Today Vol. 13 (21-22) (2008), pp.932-943.

DOI: 10.1016/j.drudis.2008.07.010

[4] P. Esposito, R. Ortesi, F. Cervellati, E. Menegatti and C. Nastruzzi: J. Microencapsul Vol. 14 (1997), pp.175-187.

[5] M. Maheshwari, A. Paradkar, S. Yamamura and S. Kadam: AAPS PharmSciTech Vol. 7(4) (2006), p. E1-E7.

[6] H.A. Gad, M.A. El-Nabarawi and S.S. El-Hady: AAPS PharmSciTech Vol. 9 (2008), pp.878-884.

[7] G. Dumortier, J.L. Grossiord, F. Agnely and J.C. Chaumeil: Pharm. Res Vol. 23(12) 2006, pp.2709-2728.

DOI: 10.1007/s11095-006-9104-4

[8] E. Dimitrova, S. Bogdanova, M. Mitcheva, I. Tanev and E. Minkov: Drug Dev. Ind. Pharm Vol. 26(12) (2000), pp.1297-1301.

DOI: 10.1081/ddc-100102312

[9] J.M. Barichello, M. Morishita, K. Takayama and T. Nagai: Int. J. Pharm Vol. 183(2) (1999), pp.125-132.

[10] A.C.A. Cassanho, A.M. Rernandes, L.D. Oliveira, C.A. Carvalho, A.O. Jorge and C.Y. Koga-Ito: Braz. Oral Res Vol. 19(2) (2005), pp.134-138.

[11] A.K. Schwach, C.N. Vivien and R. Gurny: Eur. J. Pharm. Biopharm Vol. 50 (2000), pp.83-99.

[12] R. Sanghvi, R. Narazaki, S.G. Machatha and S.H. Yalkowsky: AAPS PharmSciTech Vol. 9 (2008), pp.366-376.

DOI: 10.1208/s12249-008-9050-z

[13] I.R. Schmolka: J. Biomed. Mater. Res Vol. 6(6) (1972), pp.571-582.

[14] S.C. Miller and M.D. Donovan: Int. J. Pharm Vol. 12 (1982), pp.147-152.

[15] B. Jeong, D.S. Lee, J.I. Shon, Y.H. Bae and S.W. Kim: J. Polym. Sci. Polym. Chem Vol. 37 (1999), pp.751-760.

[16] A. Martin: Physical Pharmacy. Philadelphia, PA: Lea & Febigger; 1993:, pp.393-422.

[17] R. Alfonso, in: Remington, The science and practice of pharmacy, Easton, USA, Mack Pub. Co., 2000, p.1207.

[18] M. Maheshwari, G. Miglani, A. Mali, A. Paradkar, S. Yamamura and S. Kadam: AAPS PharmSciTech Vol. 7(3) (2006), p. E1- E10.

DOI: 10.1208/pt070376

[19] M. Malmsten and B. Lindman: Macromol Vol. 25 (1992), pp.5440-5445.

[20] N.K. Pandit and D. Wang: Int. J. Pharm Vol. 167 (1998), pp.183-189.

[21] M.V.L.B. Bentley, J.M. Marchetti, N. Ricardo, Z. Ali-Abi and J.H. Collett: Int. J. Pharm Vol. 193 (1999), pp.49-55.

[22] H.M. Kelly, P.B. Deasy, E. Ziaka and N. Claffey: Int. J. Pharm Vol. 274 (2004), pp.167-183.

[23] A. Koizumi, M. Fujii, M. Kondoh and Y. Watanabe: Eur. J. Pharma. Biopharm Vol. 57(3) (2004), pp.473-478.